Compound details
Xylogranatin G
| Compound ID | CDAMM00199 |
|---|---|
| Common name | Xylogranatin G | IUPAC name | [(4S,8S,10R,18R,19R)-18-(furan-3-yl)-4,9,9,19-tetramethyl-6,16-dioxo-5,17-dioxa-2-azapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,11,14-tetraen-10-yl] acetate |
| Molecular formula | C28H29NO7 |
| Retention time | 41.46 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 492.201 | Theoretical mz | 492.202 |
| Error | 1.21 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 5.1416 |
| Inchi key | HGFHCUWWDIJQON-ISRDKAQANA-N |
|---|---|
| Smiles | CC(=O)OC1C2=CC3=C(CCC4(C3=CC(=O)OC4C5=COC=C5)C)N=C2C6(C(C1(C)C)CC(=O)O6)C |
| Superclass | Organoheterocyclic compounds |
| Class | Quinolines and derivatives |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|